Mark your calendars! ACT-AD’s 10th Annual FDA/AD Allies Meeting is set for Thursday, November 16, 2017, at the Bethesda North Marriott Hotel and Conference Center (5701 Marinelli Road, North Bethesda, Maryland 20852). The meeting will begin at 9:30 a.m. and end by 4:00 p.m. To register for the event, go here.
Today Alzheimer’s disease, or AD, is a fatal diagnosis with death preceded by a slow, painful decline and loss of quality of life. The ACT-AD Coalition believes we have the ability to vastly improve the outlook for people with AD and thier caregivers in the next decade and we are committed to working with a […]
March 7, 2017: ACT-AD Urges Congress to Provide FDA with $2.8B in FY 2018 August 22, 2016: ACT-AD’s Bens Presents at PDUFA VI Public Meeting June 8, 2016: Prospects Are Promising for Innovation Legislation June 3, 2016: Senate Committee Acts on FY 2017 FDA Appropriations April 19, 2016: NIH Launches Consortium to Study Vascular Links to AD April 18, 2016: FDA […]